GI
CDLX icon

GAMMA Investing’s Cardlytics CDLX Stock Holding History

GAMMA Investing’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-108
Closed -$8.9K – 3600
2024
Q2 		$8.9K Buy
108
+69
+177% +$7.46K ﹤0.01% 2309
2024
Q1 		$5.58K Buy
39
+31
+388% +$2.62K ﹤0.01% 2363
2023
Q4 		$581 Buy
+8
New +$813 ﹤0.01% 2927

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

GAMMA Investing's CDLX Position: Q3 2024 in Review

GAMMA Investing sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 108 shares — an estimated $8.9K sold.

GAMMA Investing first reported a position in CDLX in Q4 2023 and held it in 3 quarters. The position peaked at $8.9K in Q2 2024. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • GAMMA Investing reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • GAMMA Investing sold 108 Cardlytics shares in Q3 2024, an estimated $8.9K.
  • GAMMA Investing first reported a position in Cardlytics in Q4 2023 and held it in 3 quarters.
  • GAMMA Investing's Cardlytics position peaked at $8.9K in Q2 2024.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.